Alps Advisors Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Alps Advisors Inc

$14.1 Billion
Q1 2024

A detailed history of Alps Advisors Inc transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Alps Advisors Inc holds 28,203 shares of KNSA stock, worth $538,677. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,203

Previous 41,896 32.68%

Holding current value

$538,677

Previous $734,000 24.25%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$17.63 - $21.74 $241,407 - $297,685	-13,693 Reduced 32.68%	28,203 $556,000
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $419,704 - $556,977	-29,207 Reduced 41.08%	41,896 $734,000
Q3 2023 Nov 14, 2023	BUY	$13.62 - $20.2 $268,436 - $398,121	19,709 Added 38.35%	71,103 $1.24 Million
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $536,553 - $846,973	51,394 New	51,394 $723,000
Q4 2021 Feb 09, 2022	SELL	$10.39 - $15.15 $872,583 - $1.27 Million	-83,983 Closed	0 $0

Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $471,682 - $672,116	41,412 Added 97.28%	83,983 $957,000
Q2 2021 Aug 11, 2021	SELL	$13.22 - $19.09 $193,791 - $279,840	-14,659 Reduced 25.61%	42,571 $593,000
Q1 2021 May 07, 2021	BUY	$16.68 - $23.97 $10,058 - $14,453	603 Added 1.06%	57,230 $1.06 Million
Q4 2020 Feb 03, 2021	BUY	$14.8 - $21.15 $838,079 - $1.2 Million	56,627 New	56,627 $1 Million
Q4 2019 Feb 07, 2020	SELL	$5.24 - $12.96 $200,026 - $494,722	-38,173 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$8.15 - $15.88 $13,040 - $25,408	-1,600 Reduced 4.02%	38,173 $325,000
Q2 2019 Aug 07, 2019	SELL	$13.2 - $20.39 $63,294 - $97,770	-4,795 Reduced 10.76%	39,773 $539,000
Q1 2019 May 01, 2019	BUY	$15.93 - $26.59 $129,271 - $215,777	8,115 Added 22.26%	44,568 $805,000
Q4 2018 Feb 04, 2019	BUY	$16.25 - $28.09 $139,100 - $240,450	8,560 Added 30.69%	36,453 $1.02 Million
Q3 2018 Oct 25, 2018	BUY	$13.23 - $30.93 $85,875 - $200,766	6,491 Added 30.33%	27,893 $711,000
Q2 2018 Aug 02, 2018	BUY	$16.73 - $20.35 $358,055 - $435,530	21,402 New	21,402 $371,000

Others Institutions Holding KNSA

# of Institutions

164

Shares Held

40.6M

Call Options Held

186K

Put Options Held

157K

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $658M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Kiniksa Pharmaceuticals, Ltd. Transaction History